CO5050337A1 - Composiciones farmaceuticas que incluyen polipeptidos il-18 y preparacion de la misma - Google Patents
Composiciones farmaceuticas que incluyen polipeptidos il-18 y preparacion de la mismaInfo
- Publication number
- CO5050337A1 CO5050337A1 CO99030928A CO99030928A CO5050337A1 CO 5050337 A1 CO5050337 A1 CO 5050337A1 CO 99030928 A CO99030928 A CO 99030928A CO 99030928 A CO99030928 A CO 99030928A CO 5050337 A1 CO5050337 A1 CO 5050337A1
- Authority
- CO
- Colombia
- Prior art keywords
- pharmaceutical compositions
- polypeptides
- compositions including
- same preparation
- polypeptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Composiciones farmacéuticas que incluyen un polipéptido quetiene al menos un 70% de identidad de la secuencia de aminoácidos de SEQ ID No: 1 sobre la longitud completa de la SEQ ID No 1 , y en combinación con un agente quimioterapéutico.Composición farmacéutica que incluye un polipéptido y un agente quimioterapéutico, conforme a los puntos 1 a 4, dicha composición con un vehículo farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8656098P | 1998-05-21 | 1998-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5050337A1 true CO5050337A1 (es) | 2001-06-27 |
Family
ID=22199389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99030928A CO5050337A1 (es) | 1998-05-21 | 1999-05-20 | Composiciones farmaceuticas que incluyen polipeptidos il-18 y preparacion de la misma |
Country Status (28)
Country | Link |
---|---|
US (1) | US6582689B1 (es) |
EP (1) | EP1079818B1 (es) |
JP (1) | JP4283998B2 (es) |
KR (1) | KR100624588B1 (es) |
CN (1) | CN1227027C (es) |
AR (1) | AR019844A1 (es) |
AT (1) | ATE245440T1 (es) |
AU (1) | AU750918B2 (es) |
BR (1) | BR9910622A (es) |
CA (1) | CA2328603A1 (es) |
CO (1) | CO5050337A1 (es) |
CZ (1) | CZ300496B6 (es) |
DE (1) | DE69909781T2 (es) |
DK (1) | DK1079818T3 (es) |
ES (1) | ES2204164T3 (es) |
GC (1) | GC0000102A (es) |
HK (1) | HK1035136A1 (es) |
HU (1) | HUP0600520A2 (es) |
IL (2) | IL139733A0 (es) |
MY (1) | MY123434A (es) |
NO (1) | NO329195B1 (es) |
NZ (1) | NZ508115A (es) |
PL (1) | PL200840B1 (es) |
PT (1) | PT1079818E (es) |
TR (1) | TR200003453T2 (es) |
TW (1) | TWI227136B (es) |
WO (1) | WO1999059565A1 (es) |
ZA (1) | ZA200006675B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03008110A (es) | 2001-03-08 | 2003-12-12 | Ares Trading Sa | Mutantes de interleucina-18, su produccion y uso. |
US20050079153A1 (en) * | 2002-08-14 | 2005-04-14 | Pfizer Inc. | Methods for enhancing immune functions in neonatal mammals by administration of IL-18 |
WO2004031276A2 (en) * | 2002-09-19 | 2004-04-15 | Centocor, Inc. | Method of inducing maturation of dendritic cells and uses therefor |
ES2322605T3 (es) * | 2004-08-20 | 2009-06-23 | Smithkline Beecham Corporation | Tratamiento de la mucositis oral e intestinal mediante la administracion de il-18 humano. |
WO2008033499A2 (en) * | 2006-09-14 | 2008-03-20 | The Trustees Of The University Of Pennsylvania | Modulation of regulatory t cells by human il-18 |
AR065803A1 (es) * | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Uso de un polipeptido de il- 18 humana y un anticuerpo anti- cd para preparar unmedicamento |
GB0803352D0 (en) | 2008-02-22 | 2008-04-02 | Ntnu Technology Transfer As | Oligopeptidic compounds and uses thereof |
US8168165B2 (en) * | 2008-12-23 | 2012-05-01 | Abbott Laboratories | Alkylated interleukin-18 compositions |
TW201506402A (zh) * | 2013-08-15 | 2015-02-16 | Tonyar Biotech Inc | 自體防潮的檢驗芯片及其製造方法 |
CA3080492A1 (en) * | 2017-09-06 | 2019-03-14 | Yale University | Interleukin-18 variants and methods of use |
KR20230117120A (ko) | 2020-11-02 | 2023-08-07 | 심카 아이엘-18, 인크. | 인터류킨-18 변이체 및 사용 방법 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
US6207641B1 (en) * | 1995-03-10 | 2001-03-27 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases |
TW581771B (en) | 1994-11-15 | 2004-04-01 | Hayashibara Biochem Lab | Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide |
JP4004088B2 (ja) | 1995-09-26 | 2007-11-07 | 株式会社林原生物化学研究所 | 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質 |
US5869535A (en) * | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
JP4024366B2 (ja) * | 1996-11-29 | 2007-12-19 | 株式会社林原生物化学研究所 | ポリペプチド |
-
1999
- 1999-05-17 TW TW088107944A patent/TWI227136B/zh not_active IP Right Cessation
- 1999-05-19 MY MYPI99001971A patent/MY123434A/en unknown
- 1999-05-19 GC GCP1999159 patent/GC0000102A/xx active
- 1999-05-20 AT AT99952068T patent/ATE245440T1/de active IP Right Revival
- 1999-05-20 CO CO99030928A patent/CO5050337A1/es unknown
- 1999-05-20 WO PCT/US1999/011160 patent/WO1999059565A1/en active IP Right Grant
- 1999-05-20 PL PL366170A patent/PL200840B1/pl not_active IP Right Cessation
- 1999-05-20 CN CNB998089842A patent/CN1227027C/zh not_active Expired - Fee Related
- 1999-05-20 PT PT99952068T patent/PT1079818E/pt unknown
- 1999-05-20 JP JP2000549230A patent/JP4283998B2/ja not_active Expired - Fee Related
- 1999-05-20 US US09/700,609 patent/US6582689B1/en not_active Expired - Fee Related
- 1999-05-20 AR ARP990102416A patent/AR019844A1/es active IP Right Grant
- 1999-05-20 CA CA002328603A patent/CA2328603A1/en not_active Abandoned
- 1999-05-20 TR TR2000/03453T patent/TR200003453T2/xx unknown
- 1999-05-20 KR KR1020007013014A patent/KR100624588B1/ko not_active IP Right Cessation
- 1999-05-20 IL IL13973399A patent/IL139733A0/xx unknown
- 1999-05-20 DE DE69909781T patent/DE69909781T2/de not_active Expired - Lifetime
- 1999-05-20 CZ CZ20004321A patent/CZ300496B6/cs not_active IP Right Cessation
- 1999-05-20 AU AU43094/99A patent/AU750918B2/en not_active Ceased
- 1999-05-20 HU HU0600520A patent/HUP0600520A2/hu unknown
- 1999-05-20 EP EP99952068A patent/EP1079818B1/en not_active Expired - Lifetime
- 1999-05-20 NZ NZ508115A patent/NZ508115A/en not_active IP Right Cessation
- 1999-05-20 DK DK99952068T patent/DK1079818T3/da active
- 1999-05-20 BR BR9910622-1A patent/BR9910622A/pt not_active Application Discontinuation
- 1999-05-20 ES ES99952068T patent/ES2204164T3/es not_active Expired - Lifetime
-
2000
- 2000-11-15 ZA ZA200006675A patent/ZA200006675B/en unknown
- 2000-11-16 IL IL139733A patent/IL139733A/en not_active IP Right Cessation
- 2000-11-20 NO NO20005857A patent/NO329195B1/no not_active IP Right Cessation
-
2001
- 2001-08-16 HK HK01105775A patent/HK1035136A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69417252D1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
DE69729786D1 (de) | Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen | |
ATE280826T1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
ATE146360T1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
ATE253893T1 (de) | Zusammensetzungen enthaltend ein peptid und polymilch-glykolsäure geeignet für die herstellung von subkutanen implantaten mit verlängerter wirkstoffabgabe | |
TR200002299T2 (tr) | Epotilon kompozisyonları. | |
CO5700784A2 (es) | Polipeptidos de virus de papiloma humano y composiciones in- munogenas | |
ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
GB9930882D0 (en) | GLP-2 formulations | |
CO5050337A1 (es) | Composiciones farmaceuticas que incluyen polipeptidos il-18 y preparacion de la misma | |
EP1032592A4 (en) | ANTIMICROBIAL PEPTIDES | |
NZ235499A (en) | Radiolabelled hirudin analogues, pharmaceutical compositions and in vitro and in vivo detection of thrombin | |
EP1129106A4 (en) | CYCLIC CONOTOXIN PEPTIDES | |
DE69728914D1 (de) | Pharmazeutische Zusammensetzung gegen durch Papillomaviren verursachte Tumoren und Infektionen | |
ES2155886T3 (es) | Antagonistas super activos del vip. | |
DE3261304D1 (en) | Retro-inverso analogues of c-terminal penta and hexapeptides of substance p. | |
FR2741076B1 (fr) | Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant | |
TR199901190T2 (xx) | Interferon-(alfa) N�kleik asitlerinin verilmesi ve sentezlenmesi i�in y�ntemler ve bile�imler. | |
AR020897A1 (es) | VECTORES VIRALES RECOMBINANTES SELECTIVAMENTE REPLICANTES , UNA COMPOSICIoN FARMACEuTICA , USO DE DICHOS VECTORES PARA LA PREPARACIoN DE COMPOSICIONES FARMACEuTICAS Y PROCECESO IN-VITRO PARA PRODUCIR UN VECTOR VIRAL SELECTIVAMENTE REPLICANTE | |
BR0010934A (pt) | Peptìdeos n-alquilados possuindo atividade antiangiogênica | |
UA48245C2 (uk) | ЗАМІЩЕНІ 1,2,3,4-ТЕТРАГІДРО-2-ДИБЕНЗОФУРАНАМІНИ ТА 2-АМІНОЦИКЛОГЕПТА[B]БЕНЗОФУРАНИ, ФАРМАЦЕВТИЧНА ЛІКАРСЬКА ФОРМА ТА СПОСІБ ПІДВИЩЕННЯ АКТИВАЦІЇ 5-НТ<sub>1F</sub> РЕЦЕПТОРА У ССАВЦЯ | |
JO1992B1 (en) | Fixed pharmaceutical compounds based on the derivatives of quinpristine and dalphopristine materials and their preparation process | |
BG101849A (en) | Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions | |
AU3739500A (en) | Protease resistant flint analogs | |
JO1999B1 (en) | Isotopes of the hormone 'LH-RH' have their uses and the chemical compounds they contain |